Hexaminolevulinate Fluorescence Cystoscopy in 2009;Le point sur les indications de l'Hexvix® en 2009

Progres en Urologie

Volumn 20, Issue SUPPL.1, 2010, Pages 50-53

  Jacqmin, D ^a   Bordier, B ^b   Guillotreau, J ^b  

^a UNIVERSITY HOSPITAL OF STRASBOURG   (France)

^b CHU RANGUEIL   (France)

Author keywords

Fluorescence cystoscopy; Non muscle invasive bladder cancer

Indexed keywords

5-AMINOLEVULINIC ACID HEXYL ESTER; AMINOLEVULINIC ACID; AMINOLEVULINIC ACID HEXYL ESTER; CARBON; DIAGNOSTIC AGENT; DRUG DERIVATIVE;

ARTICLE; BLADDER TUMOR; CYSTOSCOPY; FLUORESCENCE; HUMAN; METHODOLOGY; PRACTICE GUIDELINE; SCINTISCANNING;

AMINOLEVULINIC ACID; CARBON RADIOISOTOPES; CYSTOSCOPY; FLUORESCENCE; HUMANS; PRACTICE GUIDELINES AS TOPIC; URINARY BLADDER NEOPLASMS;

EID: 77957329148     PISSN: 11667087     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Sivalingam S, Probert JL, Schwaibold H. The role of repeat transurethral resection in the management of high-risk superficial transitional cell bladder cancer. BJU Int 2005;96:759-62.
2. Lee CS, Yoon CY, Witjes JA. The past, present and future of cystoscopy: the fusion of cystoscopy and novel imaging technology. BJU Int 2008;102:1228-33.
3. Jichlinski P, Jacqmin D. Photodynamic diagnosis in non-muscle invasive blader cancer. Eur Urol Supp 2008:529.
4. Schmidbauer J, Witjes F, Schmeller N, Donat R, Susani M, Marberger M, et al. Improved detection of urothelial carcinoma in situ with hexaminolevulinate fluorescence cystoscopy. J Urol 2004;171:135-8.
5. Grossman HB, Gomella L, Fradet Y, Morales A, Presti J, Ritenour C, et al. A phase III, multicenter comparison of hexaminolevulinate fluorescence cystoscopy and white light cystoscopy for the detection of superficial papillary lesions in patients with bladder cancer. J Urol 2007;178:62-7.
6. Fradet Y, Grossman HB, Gomella L, Lerner S, Cookson M, Albala D, et al. A comparison of hexaminolevulinate fluorescence cystoscopy and white light cystoscopy for the detection of carcinoma in situ in patients with bladder cancer: a phase III, multicenter study. J Urol 2007;178:68-73.
7. Jocham D, Witjes F, Wagner, S, Zeylemaker B, van Moorselaar J, Grimm MO, et al. Improved detection and treatment of bladder cancer using hexaminolevulinate imaging: a prospective, phase III multicenter study. J Urol 2005;174:862-6.
8. Jichlinski P, Guillou L, Karlsen SJ, Malmström PU, Jocham D, Brennhovd B, et al. Hexyl aminolevulinate fluorescence cystoscopy: new diagnostic tool for photodiagnosis of superficial bladder cancer--a multicenter study. J Urol 2003;170:226-9.
9. Stenzl AS, Roessler WR, Fradet, YF, et al. Hexvix® fluorescence cystoscopy improves detection and resection of papillary bladder cancer and reduces early recurrence: a multicentre, prospective, randomized study. Eur urol 2009: 24th annual EAU congress. Abstract 1010. Eur Urol suppl 2009;8:373.
10. Kriegmair M, Zaak D, Rothenberger KH, Rassweiler J, Jocham D, Eisenberger F, et al. Transurethral resection for bladder cancer using 5-aminolevulinic acid induced fluorescence endoscopy versus white light endoscopy. J Urol 2002;168:475-8.
11. Filbeck T, Pichlmeier U, Knuechel R, Wieland WF, Roessler W. Clinically relevant improvement of recurrence-free survival with 5-aminolevulinic acid induced fluorescence diagnosis in patients with superficial bladder tumors. J Urol 2002;168:67-71.
12. Daniltchenko DI, Riedl CR, Sachs MD, Koenig F, Daha KL, Pflueger H, et al. Long-term benefit of 5-aminolevulinic acid fluorescence assisted transurethral resection of superficial bladder cancer: 5-year results of a prospective randomized study. J Urol 2005;174:2129-33.
13. Babjuk M, Soukup V, Petrik R, Jirsa M, Dvorácek J. 5-aminolaevulinic acid-induced fluorescence cystoscopy during transurethral resection reduces the risk of recurrence in stage Ta/T1 bladder cancer. BJU Int 2005;96:798-802.
14. Denzinger S, Burger M, Walter B, Knuechel R, Roessler W, Wieland WF, et al. Clinically relevant reduction in risk of recurrence of superficial bladder cancer using 5-aminolevulinic acid-induced fluorescence diagnosis: 8-year results of prospective randomized study. Urology 2007;69:675-9.
15. Witjes JA, Douglass J. The role of hexaminolevulinate fluorescence cystoscopy in bladder cancer. Nat Clin Pract Urol 2007;4:542-9.
16. Irani J, Bernardini S, Bonnal JL, Chauvet B, Colombel M, Davin JL, et al. Urothelial tumors. Prog Urol 2007;17:1065-98.